Global Pressurized Metered-dose Inhaler Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Pressurized Metered-dose Inhaler market size is predicted to grow from US$ 6260 million in 2025 to US$ 7497 million in 2031; it is expected to grow at a CAGR of 3.0% from 2025 to 2031.
A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.
Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.
North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.
Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
LP Information, Inc. (LPI) ' newest research report, the “Pressurized Metered-dose Inhaler Industry Forecast” looks at past sales and reviews total world Pressurized Metered-dose Inhaler sales in 2024, providing a comprehensive analysis by region and market sector of projected Pressurized Metered-dose Inhaler sales for 2025 through 2031. With Pressurized Metered-dose Inhaler sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pressurized Metered-dose Inhaler industry.
This Insight Report provides a comprehensive analysis of the global Pressurized Metered-dose Inhaler landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pressurized Metered-dose Inhaler portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pressurized Metered-dose Inhaler market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pressurized Metered-dose Inhaler and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pressurized Metered-dose Inhaler.
This report presents a comprehensive overview, market shares, and growth opportunities of Pressurized Metered-dose Inhaler market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pressurized Metered-dose Inhaler market?
What factors are driving Pressurized Metered-dose Inhaler market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pressurized Metered-dose Inhaler market opportunities vary by end market size?
How does Pressurized Metered-dose Inhaler break out by Type, by Application?
The global Pressurized Metered-dose Inhaler market size is predicted to grow from US$ 6260 million in 2025 to US$ 7497 million in 2031; it is expected to grow at a CAGR of 3.0% from 2025 to 2031.
A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.
Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.
North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.
Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
LP Information, Inc. (LPI) ' newest research report, the “Pressurized Metered-dose Inhaler Industry Forecast” looks at past sales and reviews total world Pressurized Metered-dose Inhaler sales in 2024, providing a comprehensive analysis by region and market sector of projected Pressurized Metered-dose Inhaler sales for 2025 through 2031. With Pressurized Metered-dose Inhaler sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pressurized Metered-dose Inhaler industry.
This Insight Report provides a comprehensive analysis of the global Pressurized Metered-dose Inhaler landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pressurized Metered-dose Inhaler portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pressurized Metered-dose Inhaler market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pressurized Metered-dose Inhaler and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pressurized Metered-dose Inhaler.
This report presents a comprehensive overview, market shares, and growth opportunities of Pressurized Metered-dose Inhaler market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Single-dose Inhalers
- Multi-dose Inhalers
- Hospitals
- Ambulatory Surgery Centres
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Glenmark Pharmaceuticals(India)
- Novartis International AG(Switzerland)
- Propeller Health(USA)
- AstraZeneca Plc(Sweden)
- Philips Respironics(Netherlands)
- Teva Pharmaceutical Industries(Israel)
- Opko Health(USA)
- Merck(USA)
- BioCare Group(Malaysia)
What is the 10-year outlook for the global Pressurized Metered-dose Inhaler market?
What factors are driving Pressurized Metered-dose Inhaler market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pressurized Metered-dose Inhaler market opportunities vary by end market size?
How does Pressurized Metered-dose Inhaler break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pressurized Metered-dose Inhaler Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pressurized Metered-dose Inhaler by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pressurized Metered-dose Inhaler by Country/Region, 2020, 2024 & 2031
2.2 Pressurized Metered-dose Inhaler Segment by Type
2.2.1 Single-dose Inhalers
2.2.2 Multi-dose Inhalers
2.3 Pressurized Metered-dose Inhaler Sales by Type
2.3.1 Global Pressurized Metered-dose Inhaler Sales Market Share by Type (2020-2025)
2.3.2 Global Pressurized Metered-dose Inhaler Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pressurized Metered-dose Inhaler Sale Price by Type (2020-2025)
2.4 Pressurized Metered-dose Inhaler Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgery Centres
2.5 Pressurized Metered-dose Inhaler Sales by Application
2.5.1 Global Pressurized Metered-dose Inhaler Sale Market Share by Application (2020-2025)
2.5.2 Global Pressurized Metered-dose Inhaler Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pressurized Metered-dose Inhaler Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pressurized Metered-dose Inhaler Breakdown Data by Company
3.1.1 Global Pressurized Metered-dose Inhaler Annual Sales by Company (2020-2025)
3.1.2 Global Pressurized Metered-dose Inhaler Sales Market Share by Company (2020-2025)
3.2 Global Pressurized Metered-dose Inhaler Annual Revenue by Company (2020-2025)
3.2.1 Global Pressurized Metered-dose Inhaler Revenue by Company (2020-2025)
3.2.2 Global Pressurized Metered-dose Inhaler Revenue Market Share by Company (2020-2025)
3.3 Global Pressurized Metered-dose Inhaler Sale Price by Company
3.4 Key Manufacturers Pressurized Metered-dose Inhaler Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pressurized Metered-dose Inhaler Product Location Distribution
3.4.2 Players Pressurized Metered-dose Inhaler Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PRESSURIZED METERED-DOSE INHALER BY GEOGRAPHIC REGION
4.1 World Historic Pressurized Metered-dose Inhaler Market Size by Geographic Region (2020-2025)
4.1.1 Global Pressurized Metered-dose Inhaler Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pressurized Metered-dose Inhaler Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pressurized Metered-dose Inhaler Market Size by Country/Region (2020-2025)
4.2.1 Global Pressurized Metered-dose Inhaler Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pressurized Metered-dose Inhaler Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pressurized Metered-dose Inhaler Sales Growth
4.4 APAC Pressurized Metered-dose Inhaler Sales Growth
4.5 Europe Pressurized Metered-dose Inhaler Sales Growth
4.6 Middle East & Africa Pressurized Metered-dose Inhaler Sales Growth
5 AMERICAS
5.1 Americas Pressurized Metered-dose Inhaler Sales by Country
5.1.1 Americas Pressurized Metered-dose Inhaler Sales by Country (2020-2025)
5.1.2 Americas Pressurized Metered-dose Inhaler Revenue by Country (2020-2025)
5.2 Americas Pressurized Metered-dose Inhaler Sales by Type (2020-2025)
5.3 Americas Pressurized Metered-dose Inhaler Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pressurized Metered-dose Inhaler Sales by Region
6.1.1 APAC Pressurized Metered-dose Inhaler Sales by Region (2020-2025)
6.1.2 APAC Pressurized Metered-dose Inhaler Revenue by Region (2020-2025)
6.2 APAC Pressurized Metered-dose Inhaler Sales by Type (2020-2025)
6.3 APAC Pressurized Metered-dose Inhaler Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pressurized Metered-dose Inhaler by Country
7.1.1 Europe Pressurized Metered-dose Inhaler Sales by Country (2020-2025)
7.1.2 Europe Pressurized Metered-dose Inhaler Revenue by Country (2020-2025)
7.2 Europe Pressurized Metered-dose Inhaler Sales by Type (2020-2025)
7.3 Europe Pressurized Metered-dose Inhaler Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pressurized Metered-dose Inhaler by Country
8.1.1 Middle East & Africa Pressurized Metered-dose Inhaler Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pressurized Metered-dose Inhaler Revenue by Country (2020-2025)
8.2 Middle East & Africa Pressurized Metered-dose Inhaler Sales by Type (2020-2025)
8.3 Middle East & Africa Pressurized Metered-dose Inhaler Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pressurized Metered-dose Inhaler
10.3 Manufacturing Process Analysis of Pressurized Metered-dose Inhaler
10.4 Industry Chain Structure of Pressurized Metered-dose Inhaler
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pressurized Metered-dose Inhaler Distributors
11.3 Pressurized Metered-dose Inhaler Customer
12 WORLD FORECAST REVIEW FOR PRESSURIZED METERED-DOSE INHALER BY GEOGRAPHIC REGION
12.1 Global Pressurized Metered-dose Inhaler Market Size Forecast by Region
12.1.1 Global Pressurized Metered-dose Inhaler Forecast by Region (2026-2031)
12.1.2 Global Pressurized Metered-dose Inhaler Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pressurized Metered-dose Inhaler Forecast by Type (2026-2031)
12.7 Global Pressurized Metered-dose Inhaler Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Glenmark Pharmaceuticals(India)
13.1.1 Glenmark Pharmaceuticals(India) Company Information
13.1.2 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.1.3 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Glenmark Pharmaceuticals(India) Main Business Overview
13.1.5 Glenmark Pharmaceuticals(India) Latest Developments
13.2 Novartis International AG(Switzerland)
13.2.1 Novartis International AG(Switzerland) Company Information
13.2.2 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.2.3 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis International AG(Switzerland) Main Business Overview
13.2.5 Novartis International AG(Switzerland) Latest Developments
13.3 Propeller Health(USA)
13.3.1 Propeller Health(USA) Company Information
13.3.2 Propeller Health(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.3.3 Propeller Health(USA) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Propeller Health(USA) Main Business Overview
13.3.5 Propeller Health(USA) Latest Developments
13.4 AstraZeneca Plc(Sweden)
13.4.1 AstraZeneca Plc(Sweden) Company Information
13.4.2 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.4.3 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AstraZeneca Plc(Sweden) Main Business Overview
13.4.5 AstraZeneca Plc(Sweden) Latest Developments
13.5 Philips Respironics(Netherlands)
13.5.1 Philips Respironics(Netherlands) Company Information
13.5.2 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.5.3 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Philips Respironics(Netherlands) Main Business Overview
13.5.5 Philips Respironics(Netherlands) Latest Developments
13.6 Teva Pharmaceutical Industries(Israel)
13.6.1 Teva Pharmaceutical Industries(Israel) Company Information
13.6.2 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teva Pharmaceutical Industries(Israel) Main Business Overview
13.6.5 Teva Pharmaceutical Industries(Israel) Latest Developments
13.7 Opko Health(USA)
13.7.1 Opko Health(USA) Company Information
13.7.2 Opko Health(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.7.3 Opko Health(USA) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Opko Health(USA) Main Business Overview
13.7.5 Opko Health(USA) Latest Developments
13.8 Merck(USA)
13.8.1 Merck(USA) Company Information
13.8.2 Merck(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.8.3 Merck(USA) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merck(USA) Main Business Overview
13.8.5 Merck(USA) Latest Developments
13.9 BioCare Group(Malaysia)
13.9.1 BioCare Group(Malaysia) Company Information
13.9.2 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.9.3 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 BioCare Group(Malaysia) Main Business Overview
13.9.5 BioCare Group(Malaysia) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Pressurized Metered-dose Inhaler Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pressurized Metered-dose Inhaler Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Single-dose Inhalers
Table 4. Major Players of Multi-dose Inhalers
Table 5. Global Pressurized Metered-dose Inhaler Sales byType (2020-2025) & (Units)
Table 6. Global Pressurized Metered-dose Inhaler Sales Market Share byType (2020-2025)
Table 7. Global Pressurized Metered-dose Inhaler Revenue byType (2020-2025) & ($ million)
Table 8. Global Pressurized Metered-dose Inhaler Revenue Market Share byType (2020-2025)
Table 9. Global Pressurized Metered-dose Inhaler Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Pressurized Metered-dose Inhaler Sale by Application (2020-2025) & (Units)
Table 11. Global Pressurized Metered-dose Inhaler Sale Market Share by Application (2020-2025)
Table 12. Global Pressurized Metered-dose Inhaler Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pressurized Metered-dose Inhaler Revenue Market Share by Application (2020-2025)
Table 14. Global Pressurized Metered-dose Inhaler Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Pressurized Metered-dose Inhaler Sales by Company (2020-2025) & (Units)
Table 16. Global Pressurized Metered-dose Inhaler Sales Market Share by Company (2020-2025)
Table 17. Global Pressurized Metered-dose Inhaler Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pressurized Metered-dose Inhaler Revenue Market Share by Company (2020-2025)
Table 19. Global Pressurized Metered-dose Inhaler Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Pressurized Metered-dose Inhaler Producing Area Distribution and Sales Area
Table 21. Players Pressurized Metered-dose Inhaler Products Offered
Table 22. Pressurized Metered-dose Inhaler Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pressurized Metered-dose Inhaler Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global Pressurized Metered-dose Inhaler Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pressurized Metered-dose Inhaler Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pressurized Metered-dose Inhaler Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pressurized Metered-dose Inhaler Sales by Country/Region (2020-2025) & (Units)
Table 30. Global Pressurized Metered-dose Inhaler Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pressurized Metered-dose Inhaler Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pressurized Metered-dose Inhaler Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pressurized Metered-dose Inhaler Sales by Country (2020-2025) & (Units)
Table 34. Americas Pressurized Metered-dose Inhaler Sales Market Share by Country (2020-2025)
Table 35. Americas Pressurized Metered-dose Inhaler Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pressurized Metered-dose Inhaler Sales byType (2020-2025) & (Units)
Table 37. Americas Pressurized Metered-dose Inhaler Sales by Application (2020-2025) & (Units)
Table 38. APAC Pressurized Metered-dose Inhaler Sales by Region (2020-2025) & (Units)
Table 39. APAC Pressurized Metered-dose Inhaler Sales Market Share by Region (2020-2025)
Table 40. APAC Pressurized Metered-dose Inhaler Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pressurized Metered-dose Inhaler Sales byType (2020-2025) & (Units)
Table 42. APAC Pressurized Metered-dose Inhaler Sales by Application (2020-2025) & (Units)
Table 43. Europe Pressurized Metered-dose Inhaler Sales by Country (2020-2025) & (Units)
Table 44. Europe Pressurized Metered-dose Inhaler Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pressurized Metered-dose Inhaler Sales byType (2020-2025) & (Units)
Table 46. Europe Pressurized Metered-dose Inhaler Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa Pressurized Metered-dose Inhaler Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa Pressurized Metered-dose Inhaler Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pressurized Metered-dose Inhaler Sales byType (2020-2025) & (Units)
Table 50. Middle East & Africa Pressurized Metered-dose Inhaler Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Pressurized Metered-dose Inhaler
Table 52. Key Market Challenges & Risks of Pressurized Metered-dose Inhaler
Table 53. Key IndustryTrends of Pressurized Metered-dose Inhaler
Table 54. Pressurized Metered-dose Inhaler Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pressurized Metered-dose Inhaler Distributors List
Table 57. Pressurized Metered-dose Inhaler Customer List
Table 58. Global Pressurized Metered-dose Inhaler SalesForecast by Region (2026-2031) & (Units)
Table 59. Global Pressurized Metered-dose Inhaler RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pressurized Metered-dose Inhaler SalesForecast by Country (2026-2031) & (Units)
Table 61. Americas Pressurized Metered-dose Inhaler Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pressurized Metered-dose Inhaler SalesForecast by Region (2026-2031) & (Units)
Table 63. APAC Pressurized Metered-dose Inhaler Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pressurized Metered-dose Inhaler SalesForecast by Country (2026-2031) & (Units)
Table 65. Europe Pressurized Metered-dose Inhaler RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pressurized Metered-dose Inhaler SalesForecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa Pressurized Metered-dose Inhaler RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Pressurized Metered-dose Inhaler SalesForecast byType (2026-2031) & (Units)
Table 69. Global Pressurized Metered-dose Inhaler RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Pressurized Metered-dose Inhaler SalesForecast by Application (2026-2031) & (Units)
Table 71. Global Pressurized Metered-dose Inhaler RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Glenmark Pharmaceuticals(India) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 73. Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 74. Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Glenmark Pharmaceuticals(India) Main Business
Table 76. Glenmark Pharmaceuticals(India) Latest Developments
Table 77. Novartis International AG(Switzerland) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 79. Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Novartis International AG(Switzerland) Main Business
Table 81. Novartis International AG(Switzerland) Latest Developments
Table 82. Propeller Health(USA) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 83. Propeller Health(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 84. Propeller Health(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Propeller Health(USA) Main Business
Table 86. Propeller Health(USA) Latest Developments
Table 87. AstraZeneca Plc(Sweden) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 88. AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 89. AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. AstraZeneca Plc(Sweden) Main Business
Table 91. AstraZeneca Plc(Sweden) Latest Developments
Table 92. Philips Respironics(Netherlands) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 93. Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 94. Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Philips Respironics(Netherlands) Main Business
Table 96. Philips Respironics(Netherlands) Latest Developments
Table 97.Teva Pharmaceutical Industries(Israel) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 98.Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 99.Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100.Teva Pharmaceutical Industries(Israel) Main Business
Table 101.Teva Pharmaceutical Industries(Israel) Latest Developments
Table 102. Opko Health(USA) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 103. Opko Health(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 104. Opko Health(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Opko Health(USA) Main Business
Table 106. Opko Health(USA) Latest Developments
Table 107. Merck(USA) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 109. Merck(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Merck(USA) Main Business
Table 111. Merck(USA) Latest Developments
Table 112. BioCare Group(Malaysia) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 113. BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 114. BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. BioCare Group(Malaysia) Main Business
Table 116. BioCare Group(Malaysia) Latest Developments
LIST OFFIGURES
Figure 1. Picture of Pressurized Metered-dose Inhaler
Figure 2. Pressurized Metered-dose Inhaler Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pressurized Metered-dose Inhaler Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Pressurized Metered-dose Inhaler Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pressurized Metered-dose Inhaler Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pressurized Metered-dose Inhaler Sales Market Share by Country/Region (2024)
Figure 10. Pressurized Metered-dose Inhaler Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Single-dose Inhalers
Figure 12. Product Picture of Multi-dose Inhalers
Figure 13. Global Pressurized Metered-dose Inhaler Sales Market Share byType in 2025
Figure 14. Global Pressurized Metered-dose Inhaler Revenue Market Share byType (2020-2025)
Figure 15. Pressurized Metered-dose Inhaler Consumed in Hospitals
Figure 16. Global Pressurized Metered-dose Inhaler Market: Hospitals (2020-2025) & (Units)
Figure 17. Pressurized Metered-dose Inhaler Consumed in Ambulatory Surgery Centres
Figure 18. Global Pressurized Metered-dose Inhaler Market: Ambulatory Surgery Centres (2020-2025) & (Units)
Figure 19. Global Pressurized Metered-dose Inhaler Sale Market Share by Application (2024)
Figure 20. Global Pressurized Metered-dose Inhaler Revenue Market Share by Application in 2025
Figure 21. Pressurized Metered-dose Inhaler Sales by Company in 2025 (Units)
Figure 22. Global Pressurized Metered-dose Inhaler Sales Market Share by Company in 2025
Figure 23. Pressurized Metered-dose Inhaler Revenue by Company in 2025 ($ millions)
Figure 24. Global Pressurized Metered-dose Inhaler Revenue Market Share by Company in 2025
Figure 25. Global Pressurized Metered-dose Inhaler Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Pressurized Metered-dose Inhaler Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Pressurized Metered-dose Inhaler Sales 2020-2025 (Units)
Figure 28. Americas Pressurized Metered-dose Inhaler Revenue 2020-2025 ($ millions)
Figure 29. APAC Pressurized Metered-dose Inhaler Sales 2020-2025 (Units)
Figure 30. APAC Pressurized Metered-dose Inhaler Revenue 2020-2025 ($ millions)
Figure 31. Europe Pressurized Metered-dose Inhaler Sales 2020-2025 (Units)
Figure 32. Europe Pressurized Metered-dose Inhaler Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Pressurized Metered-dose Inhaler Sales 2020-2025 (Units)
Figure 34. Middle East & Africa Pressurized Metered-dose Inhaler Revenue 2020-2025 ($ millions)
Figure 35. Americas Pressurized Metered-dose Inhaler Sales Market Share by Country in 2025
Figure 36. Americas Pressurized Metered-dose Inhaler Revenue Market Share by Country (2020-2025)
Figure 37. Americas Pressurized Metered-dose Inhaler Sales Market Share byType (2020-2025)
Figure 38. Americas Pressurized Metered-dose Inhaler Sales Market Share by Application (2020-2025)
Figure 39. United States Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Pressurized Metered-dose Inhaler Sales Market Share by Region in 2025
Figure 44. APAC Pressurized Metered-dose Inhaler Revenue Market Share by Region (2020-2025)
Figure 45. APAC Pressurized Metered-dose Inhaler Sales Market Share byType (2020-2025)
Figure 46. APAC Pressurized Metered-dose Inhaler Sales Market Share by Application (2020-2025)
Figure 47. China Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 51. India Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Pressurized Metered-dose Inhaler Sales Market Share by Country in 2025
Figure 55. Europe Pressurized Metered-dose Inhaler Revenue Market Share by Country (2020-2025)
Figure 56. Europe Pressurized Metered-dose Inhaler Sales Market Share byType (2020-2025)
Figure 57. Europe Pressurized Metered-dose Inhaler Sales Market Share by Application (2020-2025)
Figure 58. Germany Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 59.France Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Pressurized Metered-dose Inhaler Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Pressurized Metered-dose Inhaler Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Pressurized Metered-dose Inhaler Sales Market Share by Application (2020-2025)
Figure 66. Egypt Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Pressurized Metered-dose Inhaler in 2025
Figure 72. Manufacturing Process Analysis of Pressurized Metered-dose Inhaler
Figure 73. Industry Chain Structure of Pressurized Metered-dose Inhaler
Figure 74. Channels of Distribution
Figure 75. Global Pressurized Metered-dose Inhaler Sales MarketForecast by Region (2026-2031)
Figure 76. Global Pressurized Metered-dose Inhaler Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Pressurized Metered-dose Inhaler Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Pressurized Metered-dose Inhaler Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Pressurized Metered-dose Inhaler Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Pressurized Metered-dose Inhaler Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pressurized Metered-dose Inhaler Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pressurized Metered-dose Inhaler by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pressurized Metered-dose Inhaler by Country/Region, 2020, 2024 & 2031
2.2 Pressurized Metered-dose Inhaler Segment by Type
2.2.1 Single-dose Inhalers
2.2.2 Multi-dose Inhalers
2.3 Pressurized Metered-dose Inhaler Sales by Type
2.3.1 Global Pressurized Metered-dose Inhaler Sales Market Share by Type (2020-2025)
2.3.2 Global Pressurized Metered-dose Inhaler Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pressurized Metered-dose Inhaler Sale Price by Type (2020-2025)
2.4 Pressurized Metered-dose Inhaler Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgery Centres
2.5 Pressurized Metered-dose Inhaler Sales by Application
2.5.1 Global Pressurized Metered-dose Inhaler Sale Market Share by Application (2020-2025)
2.5.2 Global Pressurized Metered-dose Inhaler Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pressurized Metered-dose Inhaler Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pressurized Metered-dose Inhaler Breakdown Data by Company
3.1.1 Global Pressurized Metered-dose Inhaler Annual Sales by Company (2020-2025)
3.1.2 Global Pressurized Metered-dose Inhaler Sales Market Share by Company (2020-2025)
3.2 Global Pressurized Metered-dose Inhaler Annual Revenue by Company (2020-2025)
3.2.1 Global Pressurized Metered-dose Inhaler Revenue by Company (2020-2025)
3.2.2 Global Pressurized Metered-dose Inhaler Revenue Market Share by Company (2020-2025)
3.3 Global Pressurized Metered-dose Inhaler Sale Price by Company
3.4 Key Manufacturers Pressurized Metered-dose Inhaler Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pressurized Metered-dose Inhaler Product Location Distribution
3.4.2 Players Pressurized Metered-dose Inhaler Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PRESSURIZED METERED-DOSE INHALER BY GEOGRAPHIC REGION
4.1 World Historic Pressurized Metered-dose Inhaler Market Size by Geographic Region (2020-2025)
4.1.1 Global Pressurized Metered-dose Inhaler Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pressurized Metered-dose Inhaler Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pressurized Metered-dose Inhaler Market Size by Country/Region (2020-2025)
4.2.1 Global Pressurized Metered-dose Inhaler Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pressurized Metered-dose Inhaler Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pressurized Metered-dose Inhaler Sales Growth
4.4 APAC Pressurized Metered-dose Inhaler Sales Growth
4.5 Europe Pressurized Metered-dose Inhaler Sales Growth
4.6 Middle East & Africa Pressurized Metered-dose Inhaler Sales Growth
5 AMERICAS
5.1 Americas Pressurized Metered-dose Inhaler Sales by Country
5.1.1 Americas Pressurized Metered-dose Inhaler Sales by Country (2020-2025)
5.1.2 Americas Pressurized Metered-dose Inhaler Revenue by Country (2020-2025)
5.2 Americas Pressurized Metered-dose Inhaler Sales by Type (2020-2025)
5.3 Americas Pressurized Metered-dose Inhaler Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pressurized Metered-dose Inhaler Sales by Region
6.1.1 APAC Pressurized Metered-dose Inhaler Sales by Region (2020-2025)
6.1.2 APAC Pressurized Metered-dose Inhaler Revenue by Region (2020-2025)
6.2 APAC Pressurized Metered-dose Inhaler Sales by Type (2020-2025)
6.3 APAC Pressurized Metered-dose Inhaler Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pressurized Metered-dose Inhaler by Country
7.1.1 Europe Pressurized Metered-dose Inhaler Sales by Country (2020-2025)
7.1.2 Europe Pressurized Metered-dose Inhaler Revenue by Country (2020-2025)
7.2 Europe Pressurized Metered-dose Inhaler Sales by Type (2020-2025)
7.3 Europe Pressurized Metered-dose Inhaler Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pressurized Metered-dose Inhaler by Country
8.1.1 Middle East & Africa Pressurized Metered-dose Inhaler Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pressurized Metered-dose Inhaler Revenue by Country (2020-2025)
8.2 Middle East & Africa Pressurized Metered-dose Inhaler Sales by Type (2020-2025)
8.3 Middle East & Africa Pressurized Metered-dose Inhaler Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pressurized Metered-dose Inhaler
10.3 Manufacturing Process Analysis of Pressurized Metered-dose Inhaler
10.4 Industry Chain Structure of Pressurized Metered-dose Inhaler
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pressurized Metered-dose Inhaler Distributors
11.3 Pressurized Metered-dose Inhaler Customer
12 WORLD FORECAST REVIEW FOR PRESSURIZED METERED-DOSE INHALER BY GEOGRAPHIC REGION
12.1 Global Pressurized Metered-dose Inhaler Market Size Forecast by Region
12.1.1 Global Pressurized Metered-dose Inhaler Forecast by Region (2026-2031)
12.1.2 Global Pressurized Metered-dose Inhaler Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pressurized Metered-dose Inhaler Forecast by Type (2026-2031)
12.7 Global Pressurized Metered-dose Inhaler Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Glenmark Pharmaceuticals(India)
13.1.1 Glenmark Pharmaceuticals(India) Company Information
13.1.2 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.1.3 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Glenmark Pharmaceuticals(India) Main Business Overview
13.1.5 Glenmark Pharmaceuticals(India) Latest Developments
13.2 Novartis International AG(Switzerland)
13.2.1 Novartis International AG(Switzerland) Company Information
13.2.2 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.2.3 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis International AG(Switzerland) Main Business Overview
13.2.5 Novartis International AG(Switzerland) Latest Developments
13.3 Propeller Health(USA)
13.3.1 Propeller Health(USA) Company Information
13.3.2 Propeller Health(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.3.3 Propeller Health(USA) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Propeller Health(USA) Main Business Overview
13.3.5 Propeller Health(USA) Latest Developments
13.4 AstraZeneca Plc(Sweden)
13.4.1 AstraZeneca Plc(Sweden) Company Information
13.4.2 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.4.3 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AstraZeneca Plc(Sweden) Main Business Overview
13.4.5 AstraZeneca Plc(Sweden) Latest Developments
13.5 Philips Respironics(Netherlands)
13.5.1 Philips Respironics(Netherlands) Company Information
13.5.2 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.5.3 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Philips Respironics(Netherlands) Main Business Overview
13.5.5 Philips Respironics(Netherlands) Latest Developments
13.6 Teva Pharmaceutical Industries(Israel)
13.6.1 Teva Pharmaceutical Industries(Israel) Company Information
13.6.2 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teva Pharmaceutical Industries(Israel) Main Business Overview
13.6.5 Teva Pharmaceutical Industries(Israel) Latest Developments
13.7 Opko Health(USA)
13.7.1 Opko Health(USA) Company Information
13.7.2 Opko Health(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.7.3 Opko Health(USA) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Opko Health(USA) Main Business Overview
13.7.5 Opko Health(USA) Latest Developments
13.8 Merck(USA)
13.8.1 Merck(USA) Company Information
13.8.2 Merck(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.8.3 Merck(USA) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merck(USA) Main Business Overview
13.8.5 Merck(USA) Latest Developments
13.9 BioCare Group(Malaysia)
13.9.1 BioCare Group(Malaysia) Company Information
13.9.2 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
13.9.3 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 BioCare Group(Malaysia) Main Business Overview
13.9.5 BioCare Group(Malaysia) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Pressurized Metered-dose Inhaler Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pressurized Metered-dose Inhaler Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Single-dose Inhalers
Table 4. Major Players of Multi-dose Inhalers
Table 5. Global Pressurized Metered-dose Inhaler Sales byType (2020-2025) & (Units)
Table 6. Global Pressurized Metered-dose Inhaler Sales Market Share byType (2020-2025)
Table 7. Global Pressurized Metered-dose Inhaler Revenue byType (2020-2025) & ($ million)
Table 8. Global Pressurized Metered-dose Inhaler Revenue Market Share byType (2020-2025)
Table 9. Global Pressurized Metered-dose Inhaler Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Pressurized Metered-dose Inhaler Sale by Application (2020-2025) & (Units)
Table 11. Global Pressurized Metered-dose Inhaler Sale Market Share by Application (2020-2025)
Table 12. Global Pressurized Metered-dose Inhaler Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pressurized Metered-dose Inhaler Revenue Market Share by Application (2020-2025)
Table 14. Global Pressurized Metered-dose Inhaler Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Pressurized Metered-dose Inhaler Sales by Company (2020-2025) & (Units)
Table 16. Global Pressurized Metered-dose Inhaler Sales Market Share by Company (2020-2025)
Table 17. Global Pressurized Metered-dose Inhaler Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pressurized Metered-dose Inhaler Revenue Market Share by Company (2020-2025)
Table 19. Global Pressurized Metered-dose Inhaler Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Pressurized Metered-dose Inhaler Producing Area Distribution and Sales Area
Table 21. Players Pressurized Metered-dose Inhaler Products Offered
Table 22. Pressurized Metered-dose Inhaler Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pressurized Metered-dose Inhaler Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global Pressurized Metered-dose Inhaler Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pressurized Metered-dose Inhaler Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pressurized Metered-dose Inhaler Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pressurized Metered-dose Inhaler Sales by Country/Region (2020-2025) & (Units)
Table 30. Global Pressurized Metered-dose Inhaler Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pressurized Metered-dose Inhaler Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pressurized Metered-dose Inhaler Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pressurized Metered-dose Inhaler Sales by Country (2020-2025) & (Units)
Table 34. Americas Pressurized Metered-dose Inhaler Sales Market Share by Country (2020-2025)
Table 35. Americas Pressurized Metered-dose Inhaler Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pressurized Metered-dose Inhaler Sales byType (2020-2025) & (Units)
Table 37. Americas Pressurized Metered-dose Inhaler Sales by Application (2020-2025) & (Units)
Table 38. APAC Pressurized Metered-dose Inhaler Sales by Region (2020-2025) & (Units)
Table 39. APAC Pressurized Metered-dose Inhaler Sales Market Share by Region (2020-2025)
Table 40. APAC Pressurized Metered-dose Inhaler Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pressurized Metered-dose Inhaler Sales byType (2020-2025) & (Units)
Table 42. APAC Pressurized Metered-dose Inhaler Sales by Application (2020-2025) & (Units)
Table 43. Europe Pressurized Metered-dose Inhaler Sales by Country (2020-2025) & (Units)
Table 44. Europe Pressurized Metered-dose Inhaler Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pressurized Metered-dose Inhaler Sales byType (2020-2025) & (Units)
Table 46. Europe Pressurized Metered-dose Inhaler Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa Pressurized Metered-dose Inhaler Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa Pressurized Metered-dose Inhaler Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pressurized Metered-dose Inhaler Sales byType (2020-2025) & (Units)
Table 50. Middle East & Africa Pressurized Metered-dose Inhaler Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Pressurized Metered-dose Inhaler
Table 52. Key Market Challenges & Risks of Pressurized Metered-dose Inhaler
Table 53. Key IndustryTrends of Pressurized Metered-dose Inhaler
Table 54. Pressurized Metered-dose Inhaler Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pressurized Metered-dose Inhaler Distributors List
Table 57. Pressurized Metered-dose Inhaler Customer List
Table 58. Global Pressurized Metered-dose Inhaler SalesForecast by Region (2026-2031) & (Units)
Table 59. Global Pressurized Metered-dose Inhaler RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pressurized Metered-dose Inhaler SalesForecast by Country (2026-2031) & (Units)
Table 61. Americas Pressurized Metered-dose Inhaler Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pressurized Metered-dose Inhaler SalesForecast by Region (2026-2031) & (Units)
Table 63. APAC Pressurized Metered-dose Inhaler Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pressurized Metered-dose Inhaler SalesForecast by Country (2026-2031) & (Units)
Table 65. Europe Pressurized Metered-dose Inhaler RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pressurized Metered-dose Inhaler SalesForecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa Pressurized Metered-dose Inhaler RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Pressurized Metered-dose Inhaler SalesForecast byType (2026-2031) & (Units)
Table 69. Global Pressurized Metered-dose Inhaler RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Pressurized Metered-dose Inhaler SalesForecast by Application (2026-2031) & (Units)
Table 71. Global Pressurized Metered-dose Inhaler RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Glenmark Pharmaceuticals(India) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 73. Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 74. Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Glenmark Pharmaceuticals(India) Main Business
Table 76. Glenmark Pharmaceuticals(India) Latest Developments
Table 77. Novartis International AG(Switzerland) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 79. Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Novartis International AG(Switzerland) Main Business
Table 81. Novartis International AG(Switzerland) Latest Developments
Table 82. Propeller Health(USA) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 83. Propeller Health(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 84. Propeller Health(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Propeller Health(USA) Main Business
Table 86. Propeller Health(USA) Latest Developments
Table 87. AstraZeneca Plc(Sweden) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 88. AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 89. AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. AstraZeneca Plc(Sweden) Main Business
Table 91. AstraZeneca Plc(Sweden) Latest Developments
Table 92. Philips Respironics(Netherlands) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 93. Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 94. Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Philips Respironics(Netherlands) Main Business
Table 96. Philips Respironics(Netherlands) Latest Developments
Table 97.Teva Pharmaceutical Industries(Israel) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 98.Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 99.Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100.Teva Pharmaceutical Industries(Israel) Main Business
Table 101.Teva Pharmaceutical Industries(Israel) Latest Developments
Table 102. Opko Health(USA) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 103. Opko Health(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 104. Opko Health(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Opko Health(USA) Main Business
Table 106. Opko Health(USA) Latest Developments
Table 107. Merck(USA) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck(USA) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 109. Merck(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Merck(USA) Main Business
Table 111. Merck(USA) Latest Developments
Table 112. BioCare Group(Malaysia) Basic Information, Pressurized Metered-dose Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 113. BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Product Portfolios and Specifications
Table 114. BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. BioCare Group(Malaysia) Main Business
Table 116. BioCare Group(Malaysia) Latest Developments
LIST OFFIGURES
Figure 1. Picture of Pressurized Metered-dose Inhaler
Figure 2. Pressurized Metered-dose Inhaler Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pressurized Metered-dose Inhaler Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Pressurized Metered-dose Inhaler Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pressurized Metered-dose Inhaler Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pressurized Metered-dose Inhaler Sales Market Share by Country/Region (2024)
Figure 10. Pressurized Metered-dose Inhaler Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Single-dose Inhalers
Figure 12. Product Picture of Multi-dose Inhalers
Figure 13. Global Pressurized Metered-dose Inhaler Sales Market Share byType in 2025
Figure 14. Global Pressurized Metered-dose Inhaler Revenue Market Share byType (2020-2025)
Figure 15. Pressurized Metered-dose Inhaler Consumed in Hospitals
Figure 16. Global Pressurized Metered-dose Inhaler Market: Hospitals (2020-2025) & (Units)
Figure 17. Pressurized Metered-dose Inhaler Consumed in Ambulatory Surgery Centres
Figure 18. Global Pressurized Metered-dose Inhaler Market: Ambulatory Surgery Centres (2020-2025) & (Units)
Figure 19. Global Pressurized Metered-dose Inhaler Sale Market Share by Application (2024)
Figure 20. Global Pressurized Metered-dose Inhaler Revenue Market Share by Application in 2025
Figure 21. Pressurized Metered-dose Inhaler Sales by Company in 2025 (Units)
Figure 22. Global Pressurized Metered-dose Inhaler Sales Market Share by Company in 2025
Figure 23. Pressurized Metered-dose Inhaler Revenue by Company in 2025 ($ millions)
Figure 24. Global Pressurized Metered-dose Inhaler Revenue Market Share by Company in 2025
Figure 25. Global Pressurized Metered-dose Inhaler Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Pressurized Metered-dose Inhaler Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Pressurized Metered-dose Inhaler Sales 2020-2025 (Units)
Figure 28. Americas Pressurized Metered-dose Inhaler Revenue 2020-2025 ($ millions)
Figure 29. APAC Pressurized Metered-dose Inhaler Sales 2020-2025 (Units)
Figure 30. APAC Pressurized Metered-dose Inhaler Revenue 2020-2025 ($ millions)
Figure 31. Europe Pressurized Metered-dose Inhaler Sales 2020-2025 (Units)
Figure 32. Europe Pressurized Metered-dose Inhaler Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Pressurized Metered-dose Inhaler Sales 2020-2025 (Units)
Figure 34. Middle East & Africa Pressurized Metered-dose Inhaler Revenue 2020-2025 ($ millions)
Figure 35. Americas Pressurized Metered-dose Inhaler Sales Market Share by Country in 2025
Figure 36. Americas Pressurized Metered-dose Inhaler Revenue Market Share by Country (2020-2025)
Figure 37. Americas Pressurized Metered-dose Inhaler Sales Market Share byType (2020-2025)
Figure 38. Americas Pressurized Metered-dose Inhaler Sales Market Share by Application (2020-2025)
Figure 39. United States Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Pressurized Metered-dose Inhaler Sales Market Share by Region in 2025
Figure 44. APAC Pressurized Metered-dose Inhaler Revenue Market Share by Region (2020-2025)
Figure 45. APAC Pressurized Metered-dose Inhaler Sales Market Share byType (2020-2025)
Figure 46. APAC Pressurized Metered-dose Inhaler Sales Market Share by Application (2020-2025)
Figure 47. China Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 51. India Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Pressurized Metered-dose Inhaler Sales Market Share by Country in 2025
Figure 55. Europe Pressurized Metered-dose Inhaler Revenue Market Share by Country (2020-2025)
Figure 56. Europe Pressurized Metered-dose Inhaler Sales Market Share byType (2020-2025)
Figure 57. Europe Pressurized Metered-dose Inhaler Sales Market Share by Application (2020-2025)
Figure 58. Germany Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 59.France Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Pressurized Metered-dose Inhaler Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Pressurized Metered-dose Inhaler Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Pressurized Metered-dose Inhaler Sales Market Share by Application (2020-2025)
Figure 66. Egypt Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Pressurized Metered-dose Inhaler Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Pressurized Metered-dose Inhaler in 2025
Figure 72. Manufacturing Process Analysis of Pressurized Metered-dose Inhaler
Figure 73. Industry Chain Structure of Pressurized Metered-dose Inhaler
Figure 74. Channels of Distribution
Figure 75. Global Pressurized Metered-dose Inhaler Sales MarketForecast by Region (2026-2031)
Figure 76. Global Pressurized Metered-dose Inhaler Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Pressurized Metered-dose Inhaler Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Pressurized Metered-dose Inhaler Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Pressurized Metered-dose Inhaler Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Pressurized Metered-dose Inhaler Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Dental Cabinet Market Growth 2024-2030
US$ 3,660.00
December 2024
105 pages
Global Livestock Vaccine Market Growth 2025-2031
US$ 3,660.00
January 2025
121 pages
Global Transcatheter Aortic Valve Implantation (TAVI) Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
112 pages
Global Echotherapy Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
82 pages
Global Vaccine for Non-infectious Meningitis Market Growth 2025-2031
US$ 3,660.00
October 2025
85 pages
